AGC Biologics

    OverviewSuggest Edit

    AGC Biologics is a contract development and manufacturing organization dedicated to the development and manufacture of biopharmaceuticals, from pre-clinical to commercial. Its services include cell line development, bioprocess development, formulation, analytical testing, antibody-drug development and conjugation, cell banking and storage, and protein expression.
    TypePrivate
    Founded2001
    HQBothell, WA, US
    Websiteagcbio.com
    Employee Ratings3.7

    Latest Updates

    Employees (est.) (Sept 2021)1,760(+8%)
    Cybersecurity ratingBMore

    Key People/Management at AGC Biologics

    Patricio E. Massera

    Patricio E. Massera

    Chief Executive Officer
    Kasper Møller

    Kasper Møller

    Chief Technical Officer
    Hiroshi Nishimura

    Hiroshi Nishimura

    Senior Vice President, Corporate and Strategic Planning
    Vijay Raghavan

    Vijay Raghavan

    Chief Financial Officer
    Paul Tsang

    Paul Tsang

    Executive Vice President, Global Quality
    Daisy Szabo

    Daisy Szabo

    Executive Vice President, Human Resources
    Show more

    AGC Biologics Office Locations

    AGC Biologics has offices in Bothell, Boulder, Søborg, Heidelberg and in 1 other location
    Bothell, WA, US (HQ)
    21511 23rd Dr SE
    Bothell, WA, US
    22021 20th Ave SE
    Boulder, CO, US
    5550 Airport Blvd
    Søborg, DK
    Vandtårnsvej 83
    Heidelberg, DE
    Czernyring 22
    Ichihara, JP
    10 Goikaigan
    Show all (6)

    AGC Biologics Financials and Metrics

    Summary Metrics

    Founding Date

    2001

    AGC Biologics Cybersecurity Score

    Cybersecurity ratingPremium dataset

    B

    85/100

    SecurityScorecard logo

    AGC Biologics Online and Social Media Presence

    Embed Graph

    AGC Biologics News and Updates

    AGC Biologics Expands pDNA and mRNA Manufacturing Capacity at Heidelberg Facility

    Heidelberg, Germany, Sept. 13, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced expansion plans for the company’s Heidelberg facility to increase manufacturing capacities for plasmid-DNA (pDNA) an…

    AGC Biologics Announces the Groundbreaking of its New Facility at its Copenhagen, Denmark Site

    COPENHAGEN, Aug. 20, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announces the groundbreaking of its new facility at its Copenhagen, Denmark site. This multipurpose facility will allow AGC Biologics to incre…

    AGC Biologics Appoints Tony Fraij as the new General Manager/Site Head of the Longmont, Colorado Site

    LONGMONT, Aug. 09, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced a new leadership appointment to oversee strategic development and operational excellence in large-scale C&GT production at its…

    AGC Biologics Acquires Commercial Facility, Expanding Cell & Gene Therapy Global Service Offerings

    AGC Biologics acquires Longmont, Colorado facility to expand its global footprint and increase its C&GT process development and GMP capacity AGC Biologics acquires Longmont, Colorado facility to expand its global footprint and increase its C&GT process development and GMP capacity

    Global Vascular Disrupting Agents Market Report 2021-2030 with Company Profiles of AGC Biologics, Avid Bioservices, Bionomics, Mateon Therapeutics, Myrexis, VBL Therapeutics

    DUBLIN, July 14, 2021 /PRNewswire/ -- The "Vascular Disrupting Agents Market, 2021-2030: Indications, Therapeutic Area, Molecules, Therapy, Route of Administration, and Regions" report has been added to ResearchAndMarkets.com's offering. The 'Vascular Disrupting Agents Market, 2021-2030...

    AGC Inc. Receives Best Acquisition Award for Adding the Former MolMed into AGC Biologics

    Seattle, May 19, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced their win of the M&A Award for Best Acquisition, Cross-Border into Italy, presented by KPMG, Fineurop Soditic, and others. This awar…
    Show more

    AGC Biologics Frequently Asked Questions

    • When was AGC Biologics founded?

      AGC Biologics was founded in 2001.

    • Who are AGC Biologics key executives?

      AGC Biologics's key executives are Patricio E. Massera, Kasper Møller and Hiroshi Nishimura.

    • How many employees does AGC Biologics have?

      AGC Biologics has 1,760 employees.

    • Who are AGC Biologics competitors?

      Competitors of AGC Biologics include Aldevron, Vetter Pharma and EA Pharma.

    • Where is AGC Biologics headquarters?

      AGC Biologics headquarters is located at 21511 23rd Dr SE, Bothell.

    • Where are AGC Biologics offices?

      AGC Biologics has offices in Bothell, Boulder, Søborg, Heidelberg and in 1 other location.

    • How many offices does AGC Biologics have?

      AGC Biologics has 6 offices.